These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33395971)

  • 1. In vivo microstructural heterogeneity of white matter lesions in healthy elderly and Alzheimer's disease participants using tissue compositional analysis of diffusion MRI data.
    Mito R; Dhollander T; Xia Y; Raffelt D; Salvado O; Churilov L; Rowe CC; Brodtmann A; Villemagne VL; Connelly A
    Neuroimage Clin; 2020; 28():102479. PubMed ID: 33395971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-tissue compositional analysis reveals in-vivo microstructural heterogeneity of white matter hyperintensities following stroke.
    Khan W; Egorova N; Khlif MS; Mito R; Dhollander T; Brodtmann A
    Neuroimage; 2020 Sep; 218():116869. PubMed ID: 32334092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo microstructural heterogeneity of white matter and cognitive correlates in aging using tissue compositional analysis of diffusion magnetic resonance imaging.
    Badji A; Cedres N; Muehlboeck JS; Khan W; Dhollander T; Barroso J; Ferreira D; Westman E
    Hum Brain Mapp; 2024 Mar; 45(4):e26618. PubMed ID: 38414286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the microstructural properties of normal-appearing white matter (NAWM) preceding conversion to white matter hyperintensities (WMHs) in stroke survivors.
    Khan W; Khlif MS; Mito R; Dhollander T; Brodtmann A
    Neuroimage; 2021 May; 232():117839. PubMed ID: 33577935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity.
    van Leijsen EMC; Bergkamp MI; van Uden IWM; Ghafoorian M; van der Holst HM; Norris DG; Platel B; Tuladhar AM; de Leeuw FE
    Stroke; 2018 Jun; 49(6):1386-1393. PubMed ID: 29724890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease.
    Svärd D; Nilsson M; Lampinen B; Lätt J; Sundgren PC; Stomrud E; Minthon L; Hansson O; van Westen D
    PLoS One; 2017; 12(9):e0185239. PubMed ID: 28934374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.
    Damulina A; Pirpamer L; Seiler S; Benke T; Dal-Bianco P; Ransmayr G; Struhal W; Hofer E; Langkammer C; Duering M; Fazekas F; Schmidt R
    J Alzheimers Dis; 2019; 68(2):789-796. PubMed ID: 30775995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.
    Tran P; Thoprakarn U; Gourieux E; Dos Santos CL; Cavedo E; Guizard N; Cotton F; Krolak-Salmon P; Delmaire C; Heidelberg D; Pyatigorskaya N; Ströer S; Dormont D; Martini JB; Chupin M;
    Neuroimage Clin; 2022; 33():102940. PubMed ID: 35051744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
    Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    Yang HJ; Lee S; Koh MJ; Lee HK; Kim BS; Kim KW; Park JH
    J Alzheimers Dis; 2021; 83(3):1281-1289. PubMed ID: 34420961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
    Røvang MS; Selnes P; MacIntosh BJ; Rasmus Groote I; Pålhaugen L; Sudre C; Fladby T; Bjørnerud A
    PLoS One; 2023; 18(8):e0285683. PubMed ID: 37616243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging.
    Dadar M; Maranzano J; Misquitta K; Anor CJ; Fonov VS; Tartaglia MC; Carmichael OT; Decarli C; Collins DL;
    Neuroimage; 2017 Aug; 157():233-249. PubMed ID: 28602597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.
    Scheltens P; Barkhof F; Valk J; Algra PR; van der Hoop RG; Nauta J; Wolters EC
    Brain; 1992 Jun; 115 ( Pt 3)():735-48. PubMed ID: 1628199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's and vascular disease classification using regional texture biomarkers in FLAIR MRI.
    Chan K; Fischer C; Maralani PJ; Black SE; Moody AR; Khademi A
    Neuroimage Clin; 2023; 38():103385. PubMed ID: 36989851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-mortem 7 Tesla MRI detection of white matter hyperintensities: A multidisciplinary voxel-wise comparison of imaging and histological correlates.
    Roseborough AD; Langdon KD; Hammond R; Cipriano LE; Pasternak SH; Whitehead SN; Khan AR
    Neuroimage Clin; 2020; 27():102340. PubMed ID: 32679554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report.
    Swardfager W; Yu D; Ramirez J; Cogo-Moreira H; Szilagyi G; Holmes MF; Scott CJ; Scola G; Chan PC; Chen J; Chan P; Sahlas DJ; Herrmann N; Lanctôt KL; Andreazza AC; Pettersen JA; Black SE
    Alzheimers Dement (Amst); 2017; 7():56-60. PubMed ID: 28275700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.